Clinical Trials Browser

Phase 4 × Recruiting × Nivolumab × Clear all

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Recruiting

Melanoma

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

Neoplasms

NCT07028125 2025-10-07

CANIQOL

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT06934057 2025-09-24

CABOLD

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06116461 2024-04-22

NIVOPTIMIZE

Phase 4 Recruiting

Melanoma